Hormone receptor (HR)-positive breast cancers tend to metastasize to bone, whereas HER2-positive and triple-negative breast cancers (TNBC) are more prone to visceral metastases such as liver, lung, or brain4,5. Here, ERBB2 is linked to triple-negative breast carcinoma.